Gainers Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Seres Therapeutics Announces FDA Acceptance Of Biologics License Application For Investigational Microbiome Therapeutic SER-109 For Recurrent C. Difficile Infection For Priority Review
October 26, 7:09 AM
– If approved, SER-109 expected to be the first-ever FDA-approved oral microbiome therapeutic – – PDUFA target action date is April 26, 2023, with anticipated launch soon thereafter – –
September 7, 5:45 PM
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Pfizer’s (NYSE:PFE) lead drug GBS6…
September 7, 11:27 AM
Seres Therapeutics Inc (NASDAQ: MCRB) shares are trading higher by 13.24% to $6.12 Wednesday morning after the company announced it completed the rolling submission process for its BLA to the FDA for SER-109 for recurrent C. difficile infection.
September 7, 9:02 AM
Piper Sandler analyst Edward Tenthoff maintains Seres Therapeutics (NASDAQ:MCRB) with a Overweight and raises the price target from $7 to $9.
August 2, 2:41 PM
Seres Therapeutics (NASDAQ:MCRB) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement. Analysts estimate that Seres Therapeutics will report an earnings per share (EPS) of $-0.60.
July 15, 6:27 AM
Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday.
July 8, 8:25 AM
U.S. stock futures traded lower this morning on Friday ahead of jobs report for june. Investors, meanwhile, focused on some notable insider trades.